Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in newly diagnosed type 1 diabetes in children and adolescents
2024-517483-34-00Phase 2Completed
- Sponsor
- Medical University of Warsaw
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Fenofibrate with Placebo (2 arms). Primary endpoint: Primary beta-cell function endpoint. Started Sep 2024; status: completed.
02
Drugs
fenofibrate
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2024-517483-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517483-34-00.